Cargando…

Developing and validating a novel multisource comorbidity score from administrative data: a large population-based cohort study from Italy

OBJECTIVE: To develop and validate a novel comorbidity score (multisource comorbidity score (MCS)) predictive of mortality, hospital admissions and healthcare costs using multiple source information from the administrative Italian National Health System (NHS) databases. METHODS: An index of 34 varia...

Descripción completa

Detalles Bibliográficos
Autores principales: Corrao, Giovanni, Rea, Federico, Di Martino, Mirko, De Palma, Rossana, Scondotto, Salvatore, Fusco, Danilo, Lallo, Adele, Belotti, Laura Maria Beatrice, Ferrante, Mauro, Pollina Addario, Sebastiano, Merlino, Luca, Mancia, Giuseppe, Carle, Flavia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770918/
https://www.ncbi.nlm.nih.gov/pubmed/29282274
http://dx.doi.org/10.1136/bmjopen-2017-019503
_version_ 1783293161582362624
author Corrao, Giovanni
Rea, Federico
Di Martino, Mirko
De Palma, Rossana
Scondotto, Salvatore
Fusco, Danilo
Lallo, Adele
Belotti, Laura Maria Beatrice
Ferrante, Mauro
Pollina Addario, Sebastiano
Merlino, Luca
Mancia, Giuseppe
Carle, Flavia
author_facet Corrao, Giovanni
Rea, Federico
Di Martino, Mirko
De Palma, Rossana
Scondotto, Salvatore
Fusco, Danilo
Lallo, Adele
Belotti, Laura Maria Beatrice
Ferrante, Mauro
Pollina Addario, Sebastiano
Merlino, Luca
Mancia, Giuseppe
Carle, Flavia
author_sort Corrao, Giovanni
collection PubMed
description OBJECTIVE: To develop and validate a novel comorbidity score (multisource comorbidity score (MCS)) predictive of mortality, hospital admissions and healthcare costs using multiple source information from the administrative Italian National Health System (NHS) databases. METHODS: An index of 34 variables (measured from inpatient diagnoses and outpatient drug prescriptions within 2 years before baseline) independently predicting 1-year mortality in a sample of 500 000 individuals aged 50 years or older randomly selected from the NHS beneficiaries of the Italian region of Lombardy (training set) was developed. The corresponding weights were assigned from the regression coefficients of a Weibull survival model. MCS performance was evaluated by using an internal (ie, another sample of 500 000 NHS beneficiaries from Lombardy) and three external (each consisting of 500 000 NHS beneficiaries from Emilia-Romagna, Lazio and Sicily) validation sets. Discriminant power and net reclassification improvement were used to compare MCS performance with that of other comorbidity scores. MCS ability to predict secondary health outcomes (ie, hospital admissions and costs) was also investigated. RESULTS: Primary and secondary outcomes progressively increased with increasing MCS value. MCS improved the net 1-year mortality reclassification from 27% (with respect to the Chronic Disease Score) to 69% (with respect to the Elixhauser Index). MCS discrimination performance was similar in the four regions of Italy we tested, the area under the receiver operating characteristic curves (95% CI) being 0.78 (0.77 to 0.79) in Lombardy, 0.78 (0.77 to 0.79) in Emilia-Romagna, 0.77 (0.76 to 0.78) in Lazio and 0.78 (0.77 to 0.79) in Sicily. CONCLUSION: MCS seems better than conventional scores for predicting health outcomes, at least in the general population from Italy. This may offer an improved tool for risk adjustment, policy planning and identifying patients in need of a focused treatment approach in the everyday medical practice.
format Online
Article
Text
id pubmed-5770918
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-57709182018-01-19 Developing and validating a novel multisource comorbidity score from administrative data: a large population-based cohort study from Italy Corrao, Giovanni Rea, Federico Di Martino, Mirko De Palma, Rossana Scondotto, Salvatore Fusco, Danilo Lallo, Adele Belotti, Laura Maria Beatrice Ferrante, Mauro Pollina Addario, Sebastiano Merlino, Luca Mancia, Giuseppe Carle, Flavia BMJ Open Public Health OBJECTIVE: To develop and validate a novel comorbidity score (multisource comorbidity score (MCS)) predictive of mortality, hospital admissions and healthcare costs using multiple source information from the administrative Italian National Health System (NHS) databases. METHODS: An index of 34 variables (measured from inpatient diagnoses and outpatient drug prescriptions within 2 years before baseline) independently predicting 1-year mortality in a sample of 500 000 individuals aged 50 years or older randomly selected from the NHS beneficiaries of the Italian region of Lombardy (training set) was developed. The corresponding weights were assigned from the regression coefficients of a Weibull survival model. MCS performance was evaluated by using an internal (ie, another sample of 500 000 NHS beneficiaries from Lombardy) and three external (each consisting of 500 000 NHS beneficiaries from Emilia-Romagna, Lazio and Sicily) validation sets. Discriminant power and net reclassification improvement were used to compare MCS performance with that of other comorbidity scores. MCS ability to predict secondary health outcomes (ie, hospital admissions and costs) was also investigated. RESULTS: Primary and secondary outcomes progressively increased with increasing MCS value. MCS improved the net 1-year mortality reclassification from 27% (with respect to the Chronic Disease Score) to 69% (with respect to the Elixhauser Index). MCS discrimination performance was similar in the four regions of Italy we tested, the area under the receiver operating characteristic curves (95% CI) being 0.78 (0.77 to 0.79) in Lombardy, 0.78 (0.77 to 0.79) in Emilia-Romagna, 0.77 (0.76 to 0.78) in Lazio and 0.78 (0.77 to 0.79) in Sicily. CONCLUSION: MCS seems better than conventional scores for predicting health outcomes, at least in the general population from Italy. This may offer an improved tool for risk adjustment, policy planning and identifying patients in need of a focused treatment approach in the everyday medical practice. BMJ Publishing Group 2017-12-26 /pmc/articles/PMC5770918/ /pubmed/29282274 http://dx.doi.org/10.1136/bmjopen-2017-019503 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Public Health
Corrao, Giovanni
Rea, Federico
Di Martino, Mirko
De Palma, Rossana
Scondotto, Salvatore
Fusco, Danilo
Lallo, Adele
Belotti, Laura Maria Beatrice
Ferrante, Mauro
Pollina Addario, Sebastiano
Merlino, Luca
Mancia, Giuseppe
Carle, Flavia
Developing and validating a novel multisource comorbidity score from administrative data: a large population-based cohort study from Italy
title Developing and validating a novel multisource comorbidity score from administrative data: a large population-based cohort study from Italy
title_full Developing and validating a novel multisource comorbidity score from administrative data: a large population-based cohort study from Italy
title_fullStr Developing and validating a novel multisource comorbidity score from administrative data: a large population-based cohort study from Italy
title_full_unstemmed Developing and validating a novel multisource comorbidity score from administrative data: a large population-based cohort study from Italy
title_short Developing and validating a novel multisource comorbidity score from administrative data: a large population-based cohort study from Italy
title_sort developing and validating a novel multisource comorbidity score from administrative data: a large population-based cohort study from italy
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770918/
https://www.ncbi.nlm.nih.gov/pubmed/29282274
http://dx.doi.org/10.1136/bmjopen-2017-019503
work_keys_str_mv AT corraogiovanni developingandvalidatinganovelmultisourcecomorbidityscorefromadministrativedataalargepopulationbasedcohortstudyfromitaly
AT reafederico developingandvalidatinganovelmultisourcecomorbidityscorefromadministrativedataalargepopulationbasedcohortstudyfromitaly
AT dimartinomirko developingandvalidatinganovelmultisourcecomorbidityscorefromadministrativedataalargepopulationbasedcohortstudyfromitaly
AT depalmarossana developingandvalidatinganovelmultisourcecomorbidityscorefromadministrativedataalargepopulationbasedcohortstudyfromitaly
AT scondottosalvatore developingandvalidatinganovelmultisourcecomorbidityscorefromadministrativedataalargepopulationbasedcohortstudyfromitaly
AT fuscodanilo developingandvalidatinganovelmultisourcecomorbidityscorefromadministrativedataalargepopulationbasedcohortstudyfromitaly
AT lalloadele developingandvalidatinganovelmultisourcecomorbidityscorefromadministrativedataalargepopulationbasedcohortstudyfromitaly
AT belottilauramariabeatrice developingandvalidatinganovelmultisourcecomorbidityscorefromadministrativedataalargepopulationbasedcohortstudyfromitaly
AT ferrantemauro developingandvalidatinganovelmultisourcecomorbidityscorefromadministrativedataalargepopulationbasedcohortstudyfromitaly
AT pollinaaddariosebastiano developingandvalidatinganovelmultisourcecomorbidityscorefromadministrativedataalargepopulationbasedcohortstudyfromitaly
AT merlinoluca developingandvalidatinganovelmultisourcecomorbidityscorefromadministrativedataalargepopulationbasedcohortstudyfromitaly
AT manciagiuseppe developingandvalidatinganovelmultisourcecomorbidityscorefromadministrativedataalargepopulationbasedcohortstudyfromitaly
AT carleflavia developingandvalidatinganovelmultisourcecomorbidityscorefromadministrativedataalargepopulationbasedcohortstudyfromitaly